Literature DB >> 15936090

Cross talk between growth factors and viral and cellular factors alters neuronal signaling pathways: implication for HIV-associated dementia.

Francesca Peruzzi1, Valeria Bergonzini, Susanna Aprea, Krzysztof Reiss, Bassel E Sawaya, Jay Rappaport, Shohreh Amini, Kamel Khalili.   

Abstract

HIV-associated dementia (HAD) is a serious neurological disorder affecting about 7% of people with AIDS. In the brain, HIV-1 infects a restricted number of cell types, being primarily present in macrophages and microglial cells, less abundant in astrocytes, and rarely seen in oligodendrocytes and neurons. Lack of a productive HIV-1 infection of neuronal cells suggests the presence of an indirect pathway by which the virus may determine the brain pathology and neuronal dysfunction seen in AIDS patients. Among the participants in this event, viral proteins including gp120 and Tat, along with host factors including cytokines, chemokines, and several signaling pathways have received considerable attention. In this article, we discuss the most recent concepts pertaining to the mechanisms of HIV-1-induced neuronal dysfunction by highlighting the interplay between signal transduction pathways activated by viral and host factors and their consequences in neuronal cell function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15936090     DOI: 10.1016/j.brainresrev.2005.05.002

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  7 in total

1.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

2.  HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.

Authors:  Georgette D Kanmogne; Kathy Schall; Jessica Leibhart; Bryan Knipe; Howard E Gendelman; Yuri Persidsky
Journal:  J Cereb Blood Flow Metab       Date:  2006-05-10       Impact factor: 6.200

3.  HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.

Authors:  Slava Rom; Marco Pacifici; Giovanni Passiatore; Susanna Aprea; Agnieszka Waligorska; Luis Del Valle; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2011-07-01

4.  EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.

Authors:  Brian Giunta; Demian Obregon; Hauyan Hou; Jin Zeng; Nan Sun; Veljko Nikolic; Jared Ehrhart; Douglas Shytle; Francisco Fernandez; Jun Tan
Journal:  Brain Res       Date:  2006-10-31       Impact factor: 3.252

5.  Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia.

Authors:  Valeria Bergonzini; Arianna Calistri; Cristiano Salata; Claudia Del Vecchio; Elena Sartori; Cristina Parolin; Giogio Palù
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

Review 6.  Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.

Authors:  Clarisa M Buckner; Aimée J Luers; Tina M Calderon; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroimmune Pharmacol       Date:  2006-04-13       Impact factor: 4.147

Review 7.  IGF-IR in neuroprotection and brain tumors.

Authors:  Elisa Gualco; Jin Ying Wang; Luis Del Valle; Katarzyna Urbanska; Francesca Peruzzi; Kamel Khalili; Shohreh Amini; Krzysztof Reiss
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.